Targeting histone demethylation to knock down HOXA-AS2 and HOXA-AS3 , outcome-determining lncRNAs in multiple malignancies: Effect of deferiprone, a mechanism-based disruptor of KDM6B catalysis.
Year: 2025
Type: conference-abstract
Source: Journal of Clinical Oncology
Language: English
Subfield: Cancer Research
Domain: Life Sciences
Open Access status: closed
OpenAlex ID: W4410815893
